{"id":"https://openalex.org/W7225630935","doi":"https://doi.org/10.3389/fphar.2026.1903921","title":"High-dose administration of EGFR-TKIs for NSCLC patients: a literature review","display_name":"High-dose administration of EGFR-TKIs for NSCLC patients: a literature review","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225630935","doi":"https://doi.org/10.3389/fphar.2026.1903921"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1903921","doi":"https://doi.org/10.3389/fphar.2026.1903921","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1903921","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1903921/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1903921/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100437963","display_name":"Kai Cheng","orcid":"https://orcid.org/0000-0002-3858-0798","observed_orcids":["https://orcid.org/0000-0002-3858-0798"]},"institutions":[{"id":"https://openalex.org/I150229711","display_name":"University of Electronic Science and Technology of China","ror":"https://ror.org/04qr3zq92","country_code":"CN","type":"education","lineage":["https://openalex.org/I150229711"]},{"id":"https://openalex.org/I4210118556","display_name":"Sichuan Cancer Hospital","ror":"https://ror.org/029wq9x81","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210118556"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Kai Cheng","raw_affiliation_strings":["Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China","institution_ids":["https://openalex.org/I150229711","https://openalex.org/I4210118556"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161319152","display_name":"Yan Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150229711","display_name":"University of Electronic Science and Technology of China","ror":"https://ror.org/04qr3zq92","country_code":"CN","type":"education","lineage":["https://openalex.org/I150229711"]},{"id":"https://openalex.org/I4210118556","display_name":"Sichuan Cancer Hospital","ror":"https://ror.org/029wq9x81","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210118556"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yan Chen","raw_affiliation_strings":["Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China","institution_ids":["https://openalex.org/I150229711","https://openalex.org/I4210118556"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161342976","display_name":"Xiaowen Tao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I207528943","display_name":"Chengdu Medical College","ror":"https://ror.org/01c4jmp52","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I207528943"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaowen Tao","raw_affiliation_strings":["School of Pharmacy, Chengdu Medical College"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Chengdu Medical College","institution_ids":["https://openalex.org/I207528943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101699089","display_name":"Hongtao Xiao","orcid":"https://orcid.org/0000-0001-8807-0246","observed_orcids":["https://orcid.org/0000-0001-8807-0246","https://orcid.org/0000-0003-1725-7550"]},"institutions":[{"id":"https://openalex.org/I150229711","display_name":"University of Electronic Science and Technology of China","ror":"https://ror.org/04qr3zq92","country_code":"CN","type":"education","lineage":["https://openalex.org/I150229711"]},{"id":"https://openalex.org/I4210118556","display_name":"Sichuan Cancer Hospital","ror":"https://ror.org/029wq9x81","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210118556"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"HongTao Xiao","raw_affiliation_strings":["Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China","institution_ids":["https://openalex.org/I150229711","https://openalex.org/I4210118556"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101948171","display_name":"Hua Xie","orcid":"https://orcid.org/0000-0002-6685-5138","observed_orcids":["https://orcid.org/0000-0002-6685-5138"]},"institutions":[{"id":"https://openalex.org/I150229711","display_name":"University of Electronic Science and Technology of China","ror":"https://ror.org/04qr3zq92","country_code":"CN","type":"education","lineage":["https://openalex.org/I150229711"]},{"id":"https://openalex.org/I4210118556","display_name":"Sichuan Cancer Hospital","ror":"https://ror.org/029wq9x81","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210118556"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Hua Xie","raw_affiliation_strings":["Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China","institution_ids":["https://openalex.org/I150229711","https://openalex.org/I4210118556"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5101948171"],"corresponding_institution_ids":["https://openalex.org/I150229711","https://openalex.org/I4210118556"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9580000042915344},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9789999723434448},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.9139999747276306},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.8619999885559082},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.5960000157356262},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8899999856948853},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5139999985694885},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.32199999690055847}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8605999946594238},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6207000017166138},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5235000252723694},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5123999714851379},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5117999911308289},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4415000081062317},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4410000145435333},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.36550000309944153},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.362199991941452},{"id":"https://openalex.org/C2992435398","wikidata":"https://www.wikidata.org/wiki/Q6934595","display_name":"Multicenter study","level":3,"score":0.31709998846054077},{"id":"https://openalex.org/C2780765947","wikidata":"https://www.wikidata.org/wiki/Q12033531","display_name":"Administration (probate law)","level":2,"score":0.3151000142097473},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.311599999666214},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.30709999799728394},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.27790001034736633},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.26010000705718994},{"id":"https://openalex.org/C3020318244","wikidata":"https://www.wikidata.org/wiki/Q4812187","display_name":"Large sample","level":2,"score":0.257999986410141},{"id":"https://openalex.org/C2778384578","wikidata":"https://www.wikidata.org/wiki/Q16930687","display_name":"Therapeutic approach","level":3,"score":0.25099998712539673}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fphar.2026.1903921","doi":"https://doi.org/10.3389/fphar.2026.1903921","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1903921","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1903921/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1903921","doi":"https://doi.org/10.3389/fphar.2026.1903921","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1903921","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1903921/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332531","display_name":"Wu Jieping Medical Foundation","ror":"https://ror.org/05dgwj702"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225630935.pdf","grobid_xml":"https://content.openalex.org/works/W7225630935.grobid-xml"},"referenced_works_count":101,"referenced_works":["https://openalex.org/W359524515","https://openalex.org/W976436556","https://openalex.org/W1971898273","https://openalex.org/W1997852270","https://openalex.org/W2038982031","https://openalex.org/W2051645967","https://openalex.org/W2051990692","https://openalex.org/W2060254075","https://openalex.org/W2062555290","https://openalex.org/W2082148749","https://openalex.org/W2108042184","https://openalex.org/W2112602910","https://openalex.org/W2114836670","https://openalex.org/W2126767708","https://openalex.org/W2128688922","https://openalex.org/W2138515877","https://openalex.org/W2408967834","https://openalex.org/W2507849409","https://openalex.org/W2556211322","https://openalex.org/W2605914795","https://openalex.org/W2606308058","https://openalex.org/W2749013176","https://openalex.org/W2758853572","https://openalex.org/W2772814465","https://openalex.org/W2801021134","https://openalex.org/W2941031840","https://openalex.org/W2971788939","https://openalex.org/W2988773550","https://openalex.org/W2994208520","https://openalex.org/W3006384016","https://openalex.org/W3021759477","https://openalex.org/W3034224120","https://openalex.org/W3037346151","https://openalex.org/W3039427377","https://openalex.org/W3088368515","https://openalex.org/W3135347519","https://openalex.org/W3137651391","https://openalex.org/W3150444504","https://openalex.org/W3154466284","https://openalex.org/W3165526737","https://openalex.org/W3186743916","https://openalex.org/W3199507901","https://openalex.org/W3199931827","https://openalex.org/W3205408622","https://openalex.org/W3209752725","https://openalex.org/W3212545260","https://openalex.org/W3212594364","https://openalex.org/W3213951879","https://openalex.org/W4211193262","https://openalex.org/W4220843404","https://openalex.org/W4223415363","https://openalex.org/W4224250853","https://openalex.org/W4283326608","https://openalex.org/W4284890543","https://openalex.org/W4289262068","https://openalex.org/W4297221746","https://openalex.org/W4311082421","https://openalex.org/W4317503983","https://openalex.org/W4319066765","https://openalex.org/W4320890263","https://openalex.org/W4323075120","https://openalex.org/W4324344390","https://openalex.org/W4378529111","https://openalex.org/W4383226890","https://openalex.org/W4383315118","https://openalex.org/W4389001289","https://openalex.org/W4390582547","https://openalex.org/W4391054308","https://openalex.org/W4391608749","https://openalex.org/W4393345494","https://openalex.org/W4394575391","https://openalex.org/W4396560306","https://openalex.org/W4399317480","https://openalex.org/W4400005901","https://openalex.org/W4402396557","https://openalex.org/W4403224274","https://openalex.org/W4403614286","https://openalex.org/W4405233167","https://openalex.org/W4405662420","https://openalex.org/W4406071176","https://openalex.org/W4406309737","https://openalex.org/W4409119015","https://openalex.org/W4409119860","https://openalex.org/W4410091255","https://openalex.org/W4410508493","https://openalex.org/W4410510395","https://openalex.org/W4410618303","https://openalex.org/W4410940453","https://openalex.org/W4411116920","https://openalex.org/W4411161282","https://openalex.org/W4411627206","https://openalex.org/W4411673643","https://openalex.org/W4412697031","https://openalex.org/W4412891783","https://openalex.org/W4413274801","https://openalex.org/W4416121523","https://openalex.org/W7116398133","https://openalex.org/W7128948899","https://openalex.org/W7131113215","https://openalex.org/W7131366588","https://openalex.org/W7160124395"],"related_works":["https://openalex.org/W2153740808","https://openalex.org/W1992519629","https://openalex.org/W3165282291","https://openalex.org/W2596938600","https://openalex.org/W2767977901","https://openalex.org/W2797855100","https://openalex.org/W4317503983","https://openalex.org/W4399431753","https://openalex.org/W2785298524","https://openalex.org/W7117690642"],"abstract_inverted_index":{"High-dose":[0],"EGFR-TKIs":[1],"have":[2],"been":[3],"used":[4],"as":[5,57],"an":[6],"exploratory":[7],"therapeutic":[8,39],"strategy":[9],"to":[10,93],"overcome":[11],"the":[12,15,19,63,68,97],"limitations":[13],"of":[14,21,49,70,104],"standard-dose":[16],"regimen":[17],"in":[18,25],"treatment":[20],"EGFR-mutant":[22],"NSCLC,":[23],"particularly":[24],"patients":[26,50],"with":[27,45,88],"CNS":[28],"metastases.":[29],"Available":[30],"clinical":[31,102],"evidence":[32,64],"suggests":[33],"that":[34],"high-dose":[35,105],"TKIs":[36],"confer":[37],"certain":[38],"efficacy":[40],"and":[41,80,100],"manageable":[42],"safety":[43],"profiles,":[44],"a":[46],"small":[47,74],"proportion":[48],"experiencing":[51],"\u22653":[52],"grade":[53],"adverse":[54],"events,":[55],"such":[56],"rash,":[58],"nausea,diarrhea,":[59],"aminotransferase":[60],"rise,":[61],"leukopenia.However,":[62],"is":[65],"limited":[66],"by":[67],"predominance":[69],"single-center":[71],"retrospective":[72],"studies,":[73],"sample":[75],"sizes,":[76],"heterogeneous":[77],"patient":[78],"populations":[79],"short":[81],"follow-up":[82,90],"periods.":[83],"Further":[84],"large-scale,":[85],"multicenter":[86],"studies":[87],"long-term":[89],"are":[91],"needed":[92],"define":[94],"more":[95],"clearly":[96],"efficacy,":[98],"safety,":[99],"appropriate":[101],"role":[103],"EGFR-TKI":[106],"therapy.":[107]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}